CUV 14.6% $17.38 clinuvel pharmaceuticals limited

Ann: Chair Elect Letter, page-8

  1. 582 Posts.
    lightbulb Created with Sketch. 275
    Has this become a lifestyle company for the CEO and senior management? The new chairman ( appointed by the CEO) seems only interested in retaining the poorly performing management team. Negative return over 5 years, in what should have been the most exciting period ( post FDA approval). Surely it is time for a change. Enough of the lies and false promises.

    looking forward to phi/parvismelanotide results Cy 23 as promised
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
(20min delay)
Last
$17.38
Change
2.210(14.6%)
Mkt cap ! $870.8M
Open High Low Value Volume
$15.20 $17.71 $15.16 $5.878M 346.9K

Buyers (Bids)

No. Vol. Price($)
1 1000 $17.32
 

Sellers (Offers)

Price($) Vol. No.
$17.39 100 1
View Market Depth
Last trade - 16.10pm 05/07/2024 (20 minute delay) ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.